Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-11-012413)

Filing Details

Accession Number:: 0001179110-11-012413
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-08-18 20:00:50
Reporting Period:: 2011-08-18

Filing Date:: 2011-08-18
Accepted Time:: 2011-08-18 20:00:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1158223	Affymax Inc	AFFY	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1477384	A John Orwin	C/O Affymax, Inc. 4001 Miranda Ave. Palo Alto CA 94304	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2011-08-18	12,000	$4.55	148,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

In connection with the grant of 60,000 shares of performance-based restricted stock units on September 22, 2010, 30,000 shares vested upon acceptance by the FDA of the NDA for peginesatide of which 12,000 shares were sold on August 18, 2011 pursuant to a 10b-5-1 plan in order to satisfy the tax withholding obligations that arose as a consequence of the vesting and delivery of the RSUs.